Separation of rare earths and other valuable metals from deep-eutectic solvents: a new alternative for the recycling of used NdFeB magnets

Deep-eutectic solvents (DESs) are used as a promising alternative to aqueous solutions for the recovery of valuable metals from NdFeB magnets. A deep-eutectic solvent based on choline chloride and lactic acid (molar ratio 1 : 2) was used for the leaching of rare earths and other metals from NdFeB magnets. A process for the separation of Fe, B and Co from Nd and Dy in the deep-eutectic solvent was developed by using the ionic liquid tricaprylmethylammonium thiocyanate (Aliquat 336 SCN, [A336][SCN]) diluted in toluene (0.9 M). The extraction parameters were optimized and stripping of B was efficiently carried out by HCl, while EDTA was employed for the recovery of Fe and Co. The separation of Nd and Dy was assessed by using two different types of extractants, a mixture of trialkylphosphine oxides (Cyanex 923) and bis(2-ethylhexyl) phosphoric acid (D2EHPA). Based on the distribution ratios, separation factors and the ease of subsequent stripping, Cyanex 923 was chosen as the most effective extractant. The purified Dy present in the less polar phase was easily recovered by stripping with water, while the Nd present in the deep-eutectic solvent was recovered by precipitation stripping with a stoichiometric amount of oxalic acid. Nd2O3 and Dy2O3 were recovered with a purity of 99.87% and 99.94%, respectively. The feasibility to scale up this separation process was corroborated by a setup of mixer-settlers and highlighted by the possibility to fully recover and reuse the deep-eutectic solvent and the less polar phases employed in the extractions. The new proposed system based on a deep-eutectic solvent combined with traditional organic extraction phases presented higher selectivities and efficiencies than the analogous aqueous system. Extended X-ray absorption fine structure (EXAFS) was employed to elucidate the different mechanisms for extraction of Co and Fe from the deep-eutectic solvent and from an aqueous solution

Conducting research in individual patients: lessons learnt from two series of N-of-1 trials

BACKGROUND: Double-blind randomised N-of-1 trials (N-of-1 trials) may help with decisions concerning treatment when there is doubt regarding the effectiveness and suitability of medication for individual patients. The patient is his or her own control, and receives the experimental and the control treatment during several periods of time in random order. Reports of N-of-1 trials are still relatively scarce, and the research methodology is not as firmly established as that of RCTs. Recently, we have conducted two series of N-of-1 trials in general practice. Before, during, and after data-collection, difficulties regarding outcome assessment, analysis of the results, the withdrawal of patients, and the follow-up had to be dealt with. These difficulties are described and our solutions are discussed. DISCUSSION: To prevent or anticipate difficulties in N-of-1 trials, we argue that that it is important to individualise the outcome measures, and to carefully consider the objective, type of randomisation and the analysis. It is recommended to use the same dosages and dosage forms that the patient used before the trial, to start the trial with a run-in period, to formulate both general and individualised decision rules regarding the efficacy of treatment, to adjust treatment policies immediately after the trial, and to provide adequate instructions and support if treatment is adjusted. SUMMARY: Because of the specific characteristics of N-of-1 trials it is difficult to formulate general 'how to do it' guidelines for designing N-of-1 trials. However, when the design of each N-of-1 trial is tailored to the specific characteristics of each individual patient and the underlying medical problem, most difficulties in N-of-1 trials can be prevented or overcome. In this way, N-of-1 trials may be of help when deciding on drug treatment for individual patients

Development and evaluation of an instrument for the critical appraisal of randomized controlled trials of natural products

<p>Abstract</p> <p>Background</p> <p>The efficacy of natural products (NPs) is being evaluated using randomized controlled trials (RCTs) with increasing frequency, yet a search of the literature did not identify a widely accepted critical appraisal instrument developed specifically for use with NPs. The purpose of this project was to develop and evaluate a critical appraisal instrument that is sufficiently rigorous to be used in evaluating RCTs of conventional medicines, and also has a section specific for use with single entity NPs, including herbs and natural sourced chemicals.</p> <p>Methods</p> <p>Three phases of the project included: 1) using experts and a Delphi process to reach consensus on a list of items essential in describing the identity of an NP; 2) compiling a list of non-NP items important for evaluating the quality of an RCT using systematic review methodology to identify published instruments and then compiling item categories that were part of a validated instrument and/or had empirical evidence to support their inclusion and 3) conducting a field test to compare the new instrument to a published instrument for usefulness in evaluating the quality of 3 RCTs of a NP and in applying results to practice.</p> <p>Results</p> <p>Two Delphi rounds resulted in a list of 15 items essential in describing NPs. Seventeen item categories fitting inclusion criteria were identified from published instruments for conventional medicines. The new assessment instrument was assembled based on content of the two lists and the addition of a Reviewer's Conclusion section. The field test of the new instrument showed good criterion validity. Participants found it useful in translating evidence from RCTs to practice.</p> <p>Conclusion</p> <p>A new instrument for the critical appraisal of RCTs of NPs was developed and tested. The instrument is distinct from other available assessment instruments for RCTs of NPs in its systematic development and validation. The instrument is ready to be used by pharmacy students, health care practitioners and academics and will continue to be refined as required.</p

Mechanism for Solvent Extraction of Lanthanides from Chloride Media by Basic Extractants

The solvent extraction of lanthanides from chloride media to an organic phase containing an anion exchanger in the chloride form is known to show low extraction percentages and small separation factors. The coordination chemistry of the lanthanides in combination with this kind of extractant is poorly understood. Previous work has mainly used solvent extraction based techniques (slope analysis, fittings of the extraction curves) to derive the extraction mechanism of lanthanides from chloride media. In this paper, EXAFS spectra, luminescence lifetimes, excitation and emission spectra, and organic phase loadings of lanthanides in dry, water-saturated and diluted Aliquat 336 chloride or Cyphos IL 101 have been measured. The data show the formation of the hydrated lanthanide ion [Ln(H2O)8–9]3+in undiluted and diluted Aliquat 336 and the complex [LnCl6]3−in dry Aliquat 336. The presence of the same species [Ln(H2O)8–9]3+in the aqueous and in the organic phase explains the small separation factors and the poor selectivities for the separation of mixtures of lanthanides. Changes in separation factors with increasing chloride concentrations can be explained by changes in stability of the lanthanide chloro complexes in the aqueous phase, in combination with the extraction of the hydrated lanthanide ion to the organic phase. Finally, it is shown that the organic phase can be loaded with 107 g·L−1of Nd(III) under the optimal conditions.status: publishe

A multilevel meta-analysis of single-case and small-n research on interventions for reducing challenging behavior in persons with intellectual disabilities

The effectiveness of different interventions for challenging behavior (CB) in persons with intellectual disabilities (ID) was reviewed by means of a two-phase study. First, a systematic review of 137 meta-analyses and reviews on group-study interventions for CB in persons with ID was conducted. Based on this review, hypotheses concerning the effectiveness of divergent interventions for CB and concerning the impact of variables moderating treatment effectiveness were systematically generated. Second, these hypotheses were tested by means of a multilevel meta-analysis of single-case and small-n research. Two hundred and eighty-five studies reporting on 598 individuals were examined. The average treatment effect was large and statistically significant. However, this effect varied significantly over the included studies and participants. Compared to the meta-analyses and reviews focusing on group-studies in this research domain, the results of the present multilevel meta-analysis of single-case and small-n intervention research provided more detailed knowledge on which specific CB and intervention components moderate the interventions’ effectiveness.status: publishe